Echa Updates Call for Evidence on D4 and D5
India has imposed anti-dumping duty on a Chinese chemical used in pharma industry and aluminium foil to protect domestic industry from cheap imports.
While an anti-dumping duty of up to $1.63 per kg was imposed on Aluminium foil, up to $8.71 per kg duty was slapped on imports of amoxicillin, used in pharmaceuticals. The duty on both the products would be effective for a period of five years, the finance ministry has said in separate notifications.
The commerce ministry’s investigation arm — Directorate General of Anti-Dumping and Allied Duties (DGAD) — in the separate probe had concluded that these products were dumped into India and that has caused material injury to the domestic industry.
Hindalco Industries, Raviraj Foils and Jindal India had filed the application for an anti-dumping probe into imports of aluminium foil, used for packing of medicines, processed foods and cigarette. Similarly, Aurobindo Pharma had filed the application for an anti-dumping probe on Amoxycillin from China.
Countries initiate anti-dumping probe to determine if the domestic industry has been hurt by flooding of below-cost import. As a counter-measure, they come up with duties under the multilateral WTO regime.
Anti-dumping steps are taken to ensure fair trade and provide a level-playing field to the domestic industry. They are not a measure to restrict import or cause an unjustified increase in cost of products.
2026-07-31
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
Indena aescin active ingredient successfully registered REACH
-
ECHA updates information for companies on UK withdrawal from EU
-
Global Butadiene Market Faces Heavy Headwinds as Supply Surge Outpaces Demand
-
EPA Clears Backlog of Refinery Biofuel Waivers, Sparking Fears for Ethanol Demand
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
FDA Issues Import Alert 99-38 for Guangxi Wuzhou Company Herbal Jelly Products Face Automatic Detention
Recommend Reading
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
Aficamten Beats Metoprolol in Obstructive HCM, Strengthening Case Ahead of FDA Decision
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
Why Did Ethylene Glycol Prices Rebound Again at the End of April? Are Prices Likely to Remain Strong in May?
-
Premium Global Chemical Sourcing Requests (25–29 Aug 2025)
-
In April, China's gasoline and diesel market trends declined
-
Chemical Properties of Dibenzylideneacetone
-
Calcium Phosphate Uses: Food, Supplements & Industrial Applications